LONDON, May 03, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq:FRLN) (the “Company” or “Freeline”) today announced that on April 29, 2022, the Company granted five newly hired employees non-statutory options to purchase an aggregate of 57,850 of the Company’s ordinary shares.
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here